Status:
COMPLETED
Genomic Instability in Vascular Surgeons
Lead Sponsor:
Hospital Clínico Universitario de Valladolid
Conditions:
Cytogenetic Abnormality
Radiation Exposure
Eligibility:
All Genders
Brief Summary
The past two decades have witnessed the development and growth of the endovascular techniques, however, this new technology is not exempt from risks, since its use requires an ionizing radiation expos...
Eligibility Criteria
Inclusion
- Cases
- Vascular surgeons regularly involved in endovascular procedures.
- Over 10 years of endovascular experience.
- Accept to participate in the present study.
- Controls:
- Healthy patients undergoing saphenectomy and/or phlebectomy.
- Accept to participate in the present study.
Exclusion
- Cases:
- Less than 10-year endovascular experience.
- Previous medical history of cancer.
- Have been treated with radiotherapy.
- Have been exposed to ionizing radiation outside the endovascular field.
- Not accept to participate in the present study.
- Controls:
- Previous medical history of cancer.
- Have been treated with radiotherapy.
- Have been exposed to ionizing radiation.
- Not accept to participate in the present study.
Key Trial Info
Start Date :
November 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04363190
Start Date
November 9 2018
End Date
November 5 2019
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universtario de Valladolid
Valladolid, Castille and León, Spain, 47003